MRNA - Moderna, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts13131516
Avg. Estimate-4.10.75-1.69-4.05
Low estimate-4.65-0.3-5.94-7.66
High estimate-3.291.922.992
Year ago EPS5.242.5320.12-1.69
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts11121617
Avg. Estimate319.64M2.47B7.51B6.53B
Low estimate225M1.78B5.14B4.6B
High estimate440M3.22B10.57B9.46B
Year ago sales4.75B3.36B19.26B7.51B
Sales growth (year/est)-93.30%-26.60%-61.00%-13.10%
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS4.553.294.68-1.77
Actual EPS5.242.533.610.19
Difference0.69-0.76-1.071.96
Surprise %15.20%-23.10%-22.90%110.70%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate-4.10.75-1.69-4.05
7 days ago-4.120.75-1.9-4.06
30 days ago-2.710.65-1.95-3.82
60 days ago-1.850.42-2.25-3.37
90 days ago-1.720.36-2.23-3.32
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 days1N/A11
Up last 30 days1N/A32
Down last 7 daysN/AN/AN/AN/A
Down last 30 days111N/A
Growth estimatesMRNAIndustrySector(s)S&P 500
Current qtr.-178.20%N/AN/AN/A
Next qtr.-70.40%N/AN/AN/A
Current year-108.40%N/AN/AN/A
Next year-139.60%N/AN/AN/A
Next 5 years (per annum)-49.65%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A